6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
24m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
24m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
24m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
24m ago	First Quantum Minerals Reports First Quarter 2026 Results
24m ago	District Metals Announces $10 Million Private Placement Financing

About

Lipocine Inc (NASDAQ:LPCN) — investor relations, events, news, and company updates on 6ix.

Latest News

Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression

Lipocine Announces Financial Results for the Full Year Ended December 31, 2025

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Financials

Revenue

$1.98 M

Market Cap

$14.16 M

EPS

-1.77

Community Chat

Ask AI